AN OPEN STUDY ON THE SAFETY AND EFFICACY OF FLUCONAZOLE IN THE TREATMENT OF DISSEMINATED CANDIDA INFECTIONS IN PATIENTS TREATED FOR HEMATOLOGICAL MALIGNANCY

被引:28
作者
DEPAUW, BE [1 ]
RAEMAEKERS, JMM [1 ]
DONNELLY, JP [1 ]
KULLBERG, BJ [1 ]
MEIS, JFGM [1 ]
机构
[1] UNIV NIJMEGEN ST RADBOUD HOSP,DEPT MED MICROBIOL INTERNAL MED,6500 HB NIJMEGEN,NETHERLANDS
关键词
CANDIDIASIS; NEUTROPENIA; FLUCONAZOLE;
D O I
10.1007/BF01834385
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Disseminated candidiasis is a serious infectious complication with a mortality as high as 50%. Standard therapy consists of parenteral amphotericin B which is associated with major side effects and prolonged hospitalization. The aim of the study was to assess the efficacy and safety of fluconazole in an open, noncomparative study. Fluconazole, as a single agent, was given intravenously for the first 3 days at a dose of 200 mg twice daily, followed by 200 mg twice daily orally until resolution of signs and symptoms or evident treatment failure. The study group comprised 24 consecutive patients of whom nine had acute and 15 chronic disseminated candidiasis. A clinical response was achieved in 67% of cases of acute disseminated candidiasis and in 86% of cases of chronic disseminated candidiasis. The median duration of therapy was 15 days and 6 months, respectively. Superinfections with Aspergillus fumigatus developed in five patients who were persistently neutropenic. No drug-related toxicity was registered.
引用
收藏
页码:83 / 87
页数:5
相关论文
共 24 条
[1]   FLUCONAZOLE THERAPY FOR CHRONIC DISSEMINATED CANDIDIASIS IN PATIENTS WITH LEUKEMIA AND PRIOR AMPHOTERICIN-B THERAPY [J].
ANAISSIE, E ;
BODEY, GP ;
KANTARJIAN, H ;
DAVID, C ;
BARNETT, K ;
BOW, E ;
DEFELICE, R ;
DOWNS, N ;
FILE, T ;
KARAM, G ;
POTTS, D ;
SHELTON, M ;
SUGAR, A .
AMERICAN JOURNAL OF MEDICINE, 1991, 91 (02) :142-150
[2]  
ANAISSIE EJ, 1993, 18 INT C ANT AG CHEM
[3]   FUNGAL-INFECTIONS IN CANCER-PATIENTS - AN INTERNATIONAL AUTOPSY SURVEY [J].
BODEY, G ;
BUELTMANN, B ;
DUGUID, W ;
GIBBS, D ;
HANAK, H ;
HOTCHI, M ;
MALL, G ;
MARTINO, P ;
MEUNIER, F ;
MILLIKEN, S ;
NAOE, S ;
OKUDAIRA, M ;
SCEVOLA, D ;
VANTWOUT, J .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (02) :99-109
[4]   SEPSIS SYNDROME - A VALID CLINICAL ENTITY [J].
BONE, RC ;
FISHER, CJ ;
CLEMMER, TP ;
SLOTMAN, GJ ;
METZ, CA ;
BALK, RA .
CRITICAL CARE MEDICINE, 1989, 17 (05) :389-393
[5]   ULTRASONOGRAPHY AND COMPUTED-TOMOGRAPHY IN THE EVALUATION OF HEPATIC MICRO-ABSCESSES IN THE IMMUNOSUPPRESSED PATIENT [J].
CALLEN, PW ;
FILLY, RA ;
MARCUS, FS .
RADIOLOGY, 1980, 136 (02) :433-434
[6]   COLLABORATIVE COMPARISON OF BROTH MACRODILUTION AND MICRODILUTION ANTIFUNGAL SUSCEPTIBILITY TESTS [J].
ESPINELINGROFF, A ;
KISH, CW ;
KERKERING, TM ;
FROMTLING, RA ;
BARTIZAL, K ;
GALGIANI, JN ;
VILLAREAL, K ;
PFALLER, MA ;
GERARDEN, T ;
RINALDI, MG ;
FOTHERGILL, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (12) :3138-3145
[7]   FLUCONAZOLE FAILURE IN THE TREATMENT OF INVASIVE MYCOSES [J].
EVANS, TG ;
MAYER, J ;
COHEN, S ;
CLASSEN, D ;
CARROLL, K .
JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (06) :1232-1235
[8]   A CONTROLLED TRIAL OF FLUCONAZOLE TO PREVENT FUNGAL-INFECTIONS IN PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION [J].
GOODMAN, JL ;
WINSTON, DJ ;
GREENFIELD, RA ;
CHANDRASEKAR, PH ;
FOX, B ;
KAIZER, H ;
SHADDUCK, RK ;
SHEA, TC ;
STIFF, P ;
FRIEDMAN, DJ ;
POWDERLY, WG ;
SILBER, JL ;
HOROWITZ, H ;
LICHTIN, A ;
WOLFF, SN ;
MANGAN, KF ;
SILVER, SM ;
WEISDORF, D ;
HO, WG ;
GILBERT, G ;
BUELL, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (13) :845-851
[9]   FLUCONAZOLE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN SUPERFICIAL AND SYSTEMIC MYCOSES [J].
GRANT, SM ;
CLISSOLD, SP .
DRUGS, 1990, 39 (06) :877-916
[10]   HEPATIC CANDIDIASIS - AN INCREASING PROBLEM IN IMMUNOCOMPROMISED PATIENTS [J].
HARON, E ;
FELD, R ;
TUFFNELL, P ;
PATTERSON, B ;
HASSELBACK, R ;
MATLOW, A .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (01) :17-26